Serum MMPs 7–9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease

Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement

(2011) Pia Moinzadeh et al.   EXPERIMENTAL DERMATOLOGY

Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases

(2011) Warren Strober et al.   GASTROENTEROLOGY

Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis

(2010) Kinga Musiał et al.   CELL STRESS & CHAPERONES

Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study

(2010) Pieta Lehtinen et al.   INFLAMMATORY BOWEL DISEASES

The Role of Matrix Metalloproteinases in Intestinal Epithelial Wound Healing During Normal and Inflammatory States

(2010) Dana M. Hayden et al.   JOURNAL OF SURGICAL RESEARCH

Assessment of systemic matrix metalloproteinase and their regulator response in children withHelicobacter pylorigastritis

(2010) Hilpi Rautelin et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease

(2010) Laura Mäkitalo et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab

(2010) Xabier Garcia-Albeniz et al.   TUMOR BIOLOGY

New means to monitor the effect of glucocorticoid therapy in children

(2010) Hanne Rintamäki   WORLD JOURNAL OF GASTROENTEROLOGY

Serum Matrilysin Levels Predict Outcome in Curatively Resected Colorectal Cancer Patients

(2009) Alejandro Martínez-Fernandez et al.   ANNALS OF SURGICAL ONCOLOGY

Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values

(2009) Laura Mäkitalo et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease

(2009) Nicola Eastaff-Leung et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease

(2008) Andreas N Kapsoritakis et al.   BMC GASTROENTEROLOGY

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

(2008) Michael Wagner et al.   WORLD JOURNAL OF GASTROENTEROLOGY